Skip Ribbon Commands
Skip to main content

Why working at PHO is important to me:

"Public Health Ontario has grown and evolved into one of this country’s public health leaders and allows for me to contribute credible scientific and technical advice to help advance public health immunization research and practice across the province. I feel fortunate to be a part of a centre of expertise dedicated to protecting and promoting the health of all Ontarians through the application and advancement of science and knowledge."

Shelley Deeks, Medical director, Immunization and Vaccine-Preventable Diseases
New: Scientist Profile
 
 
Watch Dr. Shelley Deeks talk about:
  • What excites her about her work
  • The impact of her research
  • Why she chose PHO

Trouble viewing? Watch on YouTube.

 

Appointments

Academic degrees and accreditations

  • Doctor of medicine, University of Toronto
  • Master of health sciences (Community Health and Epidemiology), University of Toronto
  • Fellow,  The Royal College of Physicians of Canada (FRCPC)
  • Fellow, Australian Faculty of Public Health Medicine (FAFPHM)

Areas of expertise

  • Vaccine-preventable disease control
  • Vaccine safety
  • Vaccine program evaluation
  • Immunization Science
  • Human papillomavirus vaccine

PHO research interests

  • Applied public health research specifically with a focus on immunization and vaccine-preventable diseases (VPD), disease control and outbreak management, and vaccine program evaluation.
  • Participation in the Canadian Immunization Research Network.

Current PHO research activities

  • Providing medical and scientific leadership and support on the development, research, and evaluation of vaccine and immunization programs across Ontario.
  • Investigating the impact of rotavirus immunization on acute gastroenteritis in Ontario.
  • Investigating the impact of HPV immunization on anogenital warts in Ontario.
  • Assessing Intussusception and Rotavirus Vaccine Safety in Canada Using Health Administrative Data.
  • Examining inequalities in the burden of human papillomavirus (HPV) related diseases in Canada through optimal vaccination and screening policies using a multidisciplinary model-based approach.

Other publications

  1. Advisory Committee Statement: National Advisory Committee on Immunization (NACI). Update on the recommended Human Papillomavirus (HPV) vaccine immunization schedule. Public Health Agency of Canada.
  2. Vaccine Safety: Annual report on Vaccine Safety in Ontario, 2014

 

View more researchers »

Uncontrolled print copy. Valid only on day of Print: [date]
Page updated on [date/time] 12/01/2017 11:59 AM
© , Ontario Agency for Health Protection and Promotion